Tyra Biosciences (TYRA) Change in Accured Expenses (2020 - 2026)

Tyra Biosciences' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 427.4% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (down 14.97% YoY) and the FY2025 annual result came in at $3.4 million, up 552.82% from the prior year.
• Change in Accured Expenses was $1.2 million for Q1 2026 at Tyra Biosciences, down from $2.2 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $5.1 million in Q4 2023 and bottomed at -$6.9 million in Q1 2024.
• A 5-year average of $914470.6 and a median of $1.6 million in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 9572.92% — and 2024, when it tumbled 241.54%.
• Tyra Biosciences' Change in Accured Expenses stood at $207000.0 in 2022, then surged by 2352.17% to $5.1 million in 2023, then plunged by 56.5% to $2.2 million in 2024, then retreated by 2.36% to $2.2 million in 2025, then slumped by 44.57% to $1.2 million in 2026.
• Business Quant data shows TYRA's Change in Accured Expenses at $1.2 million in Q1 2026, $2.2 million in Q4 2025, and $2.1 million in Q3 2025.